Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
Katarzyna Franciszkiewicz, Alexandre Boissonnas, Marie Boutet, et al.
Cancer Research (2012) Vol. 72, Iss. 24, pp. 6325-6332
Open Access | Times Cited: 246

Showing 1-25 of 246 citing articles:

Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen, Ira Mellman
Immunity (2013) Vol. 39, Iss. 1, pp. 1-10
Open Access | Times Cited: 5711
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo, Brian Ruffell
Nature reviews. Immunology (2019) Vol. 19, Iss. 6, pp. 369-382
Open Access | Times Cited: 1827
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
Ryuma Tokunaga, Wu Zhang, Madiha Naseem, et al.
Cancer Treatment Reviews (2017) Vol. 63, pp. 40-47
Open Access | Times Cited: 1123
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jérôme Galon, Helen K. Angell, Davide Bedognetti, et al.
Immunity (2013) Vol. 39, Iss. 1, pp. 11-26
Open Access | Times Cited: 790
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin, Rikke Holmgaard, Sumit K. Subudhi, et al.
Science Translational Medicine (2014) Vol. 6, Iss. 226
Open Access | Times Cited: 662
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams, James Smothers, Roopa Srinivasan, et al.
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 9, pp. 603-622
Closed Access | Times Cited: 432
Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites
Qilong Wang, Yi Ren, Jingyao Mu, et al.
Cancer Research (2015) Vol. 75, Iss. 12, pp. 2520-2529
Open Access | Times Cited: 272
The wound healing, chronic fibrosis, and cancer progression triad
Brad Rybinski, Janusz Franco‐Barraza, Edna Cukierman
Physiological Genomics (2014) Vol. 46, Iss. 7, pp. 223-244
Open Access | Times Cited: 229
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller, Susanne Michen, Stefanie Tietze, et al.
Journal of Immunotherapy (2015) Vol. 38, Iss. 5, pp. 197-210
Open Access | Times Cited: 218
Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer
Natalie Hartmann, Nathalia A. Giese, Thomas Giese, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 13, pp. 3422-3433
Open Access | Times Cited: 191
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
Nikita Sharma, Vineet K. Gupta, Vanessa T. Garrido, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 1, pp. 451-465
Open Access | Times Cited: 176
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
Shan Gao, Dongjuan Yang, Yan Fang, et al.
Theranostics (2018) Vol. 9, Iss. 1, pp. 126-151
Open Access | Times Cited: 166
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
Wouter Hendrickx, Ines Simeone, Samreen Anjum, et al.
OncoImmunology (2017) Vol. 6, Iss. 2, pp. e1253654-e1253654
Open Access | Times Cited: 162
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
Davide Bedognetti, Traci Spivey, Yingdong Zhao, et al.
British Journal of Cancer (2013) Vol. 109, Iss. 9, pp. 2412-2423
Open Access | Times Cited: 137
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors
Zinal Chheda, Rajesh Kumar Sharma, Venkatakrishna R. Jala, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 5, pp. 2016-2026
Open Access | Times Cited: 136
Armed oncolytic viruses: A kick-start for anti-tumor immunity
J. Fréderique de Graaf, Lisanne de Vor, Ron A. M. Fouchier, et al.
Cytokine & Growth Factor Reviews (2018) Vol. 41, pp. 28-39
Open Access | Times Cited: 131
Programmable Chemotherapy and Immunotherapy against Breast Cancer Guided by Multiplexed Fluorescence Imaging in the Second Near‐Infrared Window
Xiaoxia Hao, Chunyan Li, Yejun Zhang, et al.
Advanced Materials (2018) Vol. 30, Iss. 51
Closed Access | Times Cited: 129
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Junjie Liu, Menghuan Li, Zhong Luo, et al.
Nano Today (2017) Vol. 15, pp. 56-90
Closed Access | Times Cited: 128
The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin
Stéphanie Corgnac, Marie Boutet, Maria Kfoury, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 128
The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer
Polina Weitzenfeld, Adit Ben‐Baruch
Cancer Letters (2013) Vol. 352, Iss. 1, pp. 36-53
Closed Access | Times Cited: 126
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
Marc Hilmi, Laurent Bartholin, Cindy Neuzillet
World Journal of Gastroenterology (2018) Vol. 24, Iss. 20, pp. 2137-2151
Open Access | Times Cited: 115
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
Alice Tzeng, Byron H. Kwan, Cary F. Opel, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 11, pp. 3320-3325
Open Access | Times Cited: 107
A multi-targeted approach to suppress tumor-promoting inflammation
Abbas Samadi, Alan Bilsland, Alexandros G. Georgakilas, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S151-S184
Open Access | Times Cited: 104
CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance
Michele Mondini, Pierre-Louis Loyher, Pauline Hamon, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 3, pp. 376-387
Open Access | Times Cited: 104
CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma
J Y Liu, F. Li, L. P. Wang, et al.
British Journal of Cancer (2015) Vol. 113, Iss. 5, pp. 747-755
Open Access | Times Cited: 101
Page 1 - Next Page

Scroll to top